CORT125236
- Generic Name
- CORT125236
Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Corcept Therapeutics
- Target Recruit Count
- 82
- Registration Number
- NCT05003713
- Locations
- 🇬🇧
Site 01, Ruddington, Nottingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath